Filter
546
Text search:
Natural
immunity
Featured
Recommendations
73
New Publications
122
Language
Document type
No document type
255
Guidelines
99
Studies & Reports
84
Manuals
47
Fact sheets
23
Strategic & Response Plan
18
Training Material
17
Resource Platforms
2
Situation Updates
1
Countries / Regions
Global
33
India
19
South Africa
15
Latin America and the Carribbean
14
Kenya
12
Ethiopia
10
Nigeria
9
Africa
9
Brazil
8
Philippines
7
Western and Central Europe
7
Venezuela
7
Tanzania
6
Myanmar / Burma
6
Sierra Leone
5
Ghana
5
Uganda
5
Germany
5
Rwanda
5
Bangladesh
5
Namibia
5
Asia
5
Nepal
4
Zambia
4
Mozambique
4
Middle East and North Africa
4
Eastern Europe
4
Russia
4
Congo, Democratic Republic of
3
Lesotho
3
Vietnam
3
United Kingdom
3
Liberia
2
Zimbabwe
2
Pakistan
2
Turkey
2
Thailand
2
China
2
Malawi
2
Ukraine
2
Botswana
2
Yemen
2
West and Central Africa
2
Spain
2
USA
1
Haiti
1
South Sudan
1
Lebanon
1
Syria
1
Cambodia
1
Indonesia
1
Singapore
1
Papua New Guinea
1
Argentina
1
Dominican Republic
1
Peru
1
Eswatini/ Swaziland
1
North Macedonia
1
Cuba
1
Colombia
1
Honduras
1
Ecuador
1
El Salvador
1
Bolivia
1
Guatemala
1
Mexico
1
Nicaragua
1
Chile
1
East and Southern Africa
1
South–East Asia Region
1
Western Pacific Region
1
Other region
1
Laos
1
France
1
Portugal
1
South Korea
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
159
Clinical Guidelines
76
Public Health
38
Key Resources
32
Women & Child Health
24
Capacity Building
10
Pharmacy & Technologies
7
Annual Report MEDBOX
1
Toolboxes
COVID-19
98
TB
44
NTDs
35
Rapid Response
24
Planetary Health
24
Malaria
23
HIV
20
2.0 Rapid Response
15
Cholera
12
AMR
10
Polio
8
Refugee
8
Mental Health
8
Global Health Education
8
NCDs
8
Ebola & Marburg
7
Conflict
7
Zika
7
Natural Hazards
5
Caregiver
5
Health Financing Toolbox
4
Disability
3
Specific Hazards
2
Typhoon
1
Pharmacy
1
10 May 2021
This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020.
This update is focused on what is currently understood about SARS-CoV-2
...
Natural immunity against COVID-19
Scientific report 10 May 2021
26 March 2021 Slideset updated regularly to include the latest data on the evolution and duration of COVID-19 symptoms and prevalence and duration of natural immunity.
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt
...
Risk assessment and priority interventions
Handbook of Foodborne Pathogenic Microorganisms and Natural Toxins
COVID-19 vaccine hesitancy is currently one of the main obstacles to worldwide herd immunity and socioeconomic recovery. Because vaccine coverage can vary between and within countries, it is important
to identify sources of variation so that polici
...
Vaccines (shots) are one of the tools we have to fight the COVID-19 pandemic. Vaccines work with your body’s natural defenses so your body will be ready to fight the virus.
Alternative Languages: Arabic | Spanish | Korean | Russian | Simplified C
...
One health Response to AMR Containment.
In a significant move for the public health sector, Kerala has become the first state in India to launch an action plan to combat the growing cases of antimicrobial immunity, arising primarily from irrational
...
The backsliding of immunization coverage during the COVID-19 pandemic, combined with delayed catch-up efforts has resulted in a large and growing immunity gap. There is an urgent need to close this gap, and enable millions of missed children to be v
...
The WHO handbook “Epidemiological Data Analysis for the Early Warning Alert and Response Network (EWARN) in Humanitarian Emergencies” explains how to collect, analyse, interpret, and share health data during crises such as conflicts or natural d
...
The European Respiratory Society (ERS)/American Thoracic Society (ATS) Task Force on severe asthma includes an updated definition of severe asthma, a discussion of severe asthma phenotypes in relation to genetics, natural history, pathobiology and p
...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig
...
The study on single-dose cholera vaccine in Zambia evaluates the effectiveness of using a single dose of the oral cholera vaccine (OCV) during a 2016 outbreak in Lusaka. Due to limited vaccine supply, authorities opted for a one-dose emergency campaign instead of the usual two-dose regimen. A matche
...
The global coronavirus pandemic, which has brought death to hundreds of thousands and serious illness to millions more, also poses profound spiritual questions and real challenges to Christians everywhere.
The pandemic itself has become a fundamental test of our faith in God and God’s providence,
...
CEPI is seeking to raise $3.5 billion to implement CEPI’s next 5-year plan. To mitigate the immediate threat of COVID-19 variants, it is activating key elements of this plan now—and seeking to mobilise a portion of this $3.5 billion in 2021. We have already launched R&D programmes to initiate de
...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for
...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re
...
